IMAX.NYSEImax CORP

Form 4: IMAX CCO Exercises, Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


IMAX Chief Commercial Officer Giovanni M. Dolci exercised stock options and subsequently sold the acquired common shares on November 10, 2025, as part of a pre-arranged 10b5-1 plan.

Summary

  • Giovanni M. Dolci, Chief Commercial Officer & EVP of IMAX CORP, engaged in a transaction involving the company's common shares.
  • On November 10, 2025, Mr. Dolci converted 6,188 stock options into common shares at an exercise price of $22.49 per share.
  • Immediately following the conversion, Mr. Dolci sold all 6,188 newly acquired common shares at a price of $34.2452 per share.
  • The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating it was pre-arranged.
  • Following these transactions, Mr. Dolci's direct beneficial ownership of common shares remained at 33,000.
  • Mr. Dolci also holds 21,574 restricted share units after these transactions.
  • The stock options exercised were issued in 2019 and were set to expire on March 7, 2026.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. This type of transaction is generally considered neutral as it's often for personal financial planning rather than a signal about the company's immediate prospects.

Positives

  • The transaction was conducted under a Rule 10b5-1 plan, which suggests a pre-scheduled, non-discretionary sale, often mitigating concerns about insider selling.
  • The sale price of $34.2452 per share is significantly higher than the exercise price of $22.49, indicating a substantial gain for the officer on the exercised options.

Negatives

  • The sale of shares by a Chief Commercial Officer, even if pre-planned, can sometimes be perceived as a lack of confidence by some investors, although this is often a personal financial decision.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This is a routine insider transaction and does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: The transaction is a routine insider sale under a 10b5-1 plan, which typically has minimal direct impact on shareholders. The officer's remaining holdings indicate continued alignment with shareholder interests.

Key Dates

DateDescription
2019Year stock options were issued to Giovanni M. Dolci.
03/07/2020First installment of 1,237 stock options became exercisable.
03/07/2021Second installment of 1,547 stock options became exercisable.
03/07/2022Third installment of 1,547 stock options became exercisable.
03/07/2023Fourth installment of 1,857 stock options became exercisable.
11/10/2025Date of stock option conversion and subsequent sale of common shares by Giovanni M. Dolci.
03/07/2026Expiration date of the stock options.

Keywords

IMAX, Giovanni Dolci, Insider Transaction, Form 4, Stock Options, Executive Compensation, 10b5-1 Plan, Share Sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.